The government anticipates that the revenue loss will be temporary and can be offset by increased consumer spending. Earlier ...

India stands on the brink of a weight-loss revolution as semaglutide, the key ingredient in blockbuster drugs like Ozempic and Wegovy, goes off-patent in 2026 across over 80 countries, including India ...